Literature DB >> 2954636

Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma.

L Grazioli, M Sensi, G Parmiani.   

Abstract

BALB/c mice were immunized with the syngeneic 3-methylcholanthrene-induced fibrosarcoma CA-2 by the growth and excision method. When lymphoid cells from different organs of these tumor-free mice were tested in a direct 51Cr-release assay, peritoneal exudate cells but not spleen cells displayed specific cytotoxicity against the syngeneic tumor target. A cytotoxic response could be obtained by tumor-immune spleen cells when cultured in a mixed lymphocyte tumor cell culture (MLTC) at high but not low density although at the same effector/stimulator ratio. Lack of cytotoxic activity in low density MLTC was not due to an impairment of cytotoxic precursors since cytotoxicity was rescued by adding exogenous interleukin-2 in experimental conditions in which no lymphokine-activated killer cells could develop relevant anti-CA-2 lysis. When low density MLTC were supplemented with either 800 R-irradiated cells or nonirradiated, negatively selected Lyt 1+ cells from the same immune mice, induction of a cytotoxic response against CA-2 occurred and interleukin-2 production became detectable. Additional studies indicated that spleen cells of CA-2-immune mice were also impaired in their ability to provide help to syngeneic thymocytes for the generation of cytotoxic T lymphocytes against C57BL/6J alloantigens. Dilution effect of helper cells due to immunization procedures was excluded since spleen cells of mice immunized against another BALB/c tumor, the YC8 lymphoma, or against DBA/2 minor histocompatibility antigens provided good help to thymocytes against the same alloantigens. These results indicate that tumor-immune animals may also have selective T helper defects in an important lymphoid organ like spleen.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954636     DOI: 10.1007/bf00205636

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  27 in total

Review 1.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

2.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

3.  Characterization of effector cells mediating antitumor activity in spleen cells of tumor-bearing mice.

Authors:  S Fuyama; H Yamamoto; S Arai
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

4.  In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.

Authors:  G Forni; M Giovarelli
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.

Authors:  C C Ting; D Rodrigues
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

6.  Rescue of the tumor-specific immune response of aged mice in vitro.

Authors:  J L Urban; H Schreiber
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

7.  Regulatory mechanisms in cytotoxic T lymphocyte development. I. A suppressor T cell subset that regulates the proliferative stage of CTL development.

Authors:  B M Susskind; V J Merluzzi; R B Faanes; M A Palladino; Y S Choi
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

8.  A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.

Authors:  L M Pilarski
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

9.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.

Authors:  H B Hewitt; E R Blake; A S Walder
Journal:  Br J Cancer       Date:  1976-03       Impact factor: 7.640

View more
  1 in total

1.  Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.

Authors:  K Ryoyama; C Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.